๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase I-II clinical trial of californium-252. Treatment of stage IB carcinoma of the cervix

โœ Scribed by Yosh Maruyama; John R. Vannagell; Justine Yoneda; Elvis Donaldson; Holly Gallion; Ken Rowley; Richard Kryscio; Joseph L. Beach


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
656 KB
Volume
59
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A Phase II trial of methotrexate, vinbla
โœ Christos A. Papadimitriou; Meletios A. Dimopoulos; Nikolaos Giannakoulis; Kyrill ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 68 KB ๐Ÿ‘ 3 views

## Background: Patients with metastatic carcinoma of the uterine cervix have limited survival. thus, new chemotherapeutic agents and combinations are needed to improve patient outcome. ## Methods: Twenty-seven patients with stage iv primary or recurrent carcinoma of the uterine cervix were assign

Parametrial implants in the treatment of
โœ Thongbliew Prempree; Vinita Patanaphan; Wilfred Sewchand; Ralph M. Scott ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 895 KB

Local failure (in the cervix and pelvic wall) continues to be a major reason for poor results following conventional radiation treatment of Stage IIIB (FIGO) carcinoma of the cervix. Attempting to minimize this local failure, in 1975 and early 1976, the Radiation Therapy Department, University of Ma

Phase II randomized clinical trial of LC
โœ Tomohiko Okawa; Midori Kita; Tatsuo Arai; Kouyo Iida; Takushi Dokiya; Yoshihiro ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 648 KB

The clinical efficacy of LC9018, a biological response modifier prepared from heat-killed Lactobacillus casei YIT9018, used in combination with radiation was studied in a randomized controlled trial on 61 patients with carcinoma of the uterine cervix of Stage IIB or 111. The combination therapy with